Skip to content

DexCom

US · DXCM #635 by market cap Listed 2005
84.30 +0.91 +1.09%
Live - 5344 symbols - heartbeat 156s ago · 2026-10-08 08:22
Pre-market 85.00 +0.83%
After-hours 84.30 0.00%
Overnight 84.24 -0.07%
Market cap
31.81B
P/B
12.13
EPS
2.09
Reader sentiment Are you bullish or bearish on DXCM?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.4 percentage points.

Institutional ownership

Held by institutions
105.19% -0.40pp
Institutions
1,210 -11
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund85.31%
Public Company5.46%
Hedge Fund5.30%
Government Pension Fund3.17%
Private Company3.17%
Sovereign Wealth Fund2.00%
Insurance Company0.25%
Individual/Insider0.24%
VC/PE Fund0.21%

Top holders as of 2026-06-30

BlackRock 10.13% · 38.24M sh
Vanguard Capital Management, LLC 7.27% · 27.43M sh
Vanguard Portfolio Management, LLC 5.21% · 19.66M sh
State Street Global Advisors 4.87% · 18.38M sh
UBS Asset Management 4.59% · 17.33M sh
Baillie Gifford 3.92% · 14.80M sh
Invesco Capital Management LLC 3.86% · 14.58M sh
Geode Capital Management, LLC 3.29% · 12.43M sh
AllianceBernstein 3.10% · 11.69M sh
Wellington Management Group 2.26% · 8.53M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 14 buys · 35 sells

NameRoleStake
Jacob Leach Chief Operating Officer 0.09%
Kevin Sayer Chairperson & CEO 0.05%
Steven Altman Independent Director 0.02%
Jereme Sylvain Chief Financial Officer 0.02%
Sadie Stern Executive Vice President 0.01%
Mark Foletta Lead Independent Director 0.01%
Richard Collins Independent Director 0.01%
Nicholas Augustinos Independent Director 0.01%
Michael Brown Chief Legal Officer 0.01%
Bridgette Heller Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-27 Sadie Stern Executive Vice President Automatic Disposition -2,565 $86.15
2026-09-14 Nicholas Augustinos Independent Director Automatic Disposition -8,089 $84.02–84.04
2026-09-14 Nicholas Augustinos Independent Director Intent to Sell (Form 144) -6,539 $84.04
2026-09-14 Michael Brown Chief Legal Officer Automatic Disposition -1,700 $84.04
2026-09-13 Nicholas Augustinos Independent Director Intent to Sell (Form 144) -1,550 $84.02
2026-09-09 Glenn Boehnlein Independent Director Other Acquisition +5,841 --
2026-09-09 Glenn Boehnlein Independent Director Initial Statement of Beneficial 0 --
2026-09-09 Jereme Sylvain Chief Financial Officer Automatic Disposition -3,638 $83.27
2026-08-26 Sadie Stern Executive Vice President Automatic Disposition -2,565 $88.37
2026-08-21 Jacob Leach Chief Operating Officer Sale to Issuer -1,451 $92.34
2026-08-21 Jereme Sylvain Chief Financial Officer Sale to Issuer -1,451 $92.34
2026-08-21 Sadie Stern Executive Vice President Sale to Issuer -1,451 $92.34
2026-08-21 Michael Brown Chief Legal Officer Sale to Issuer -1,451 $92.34
2026-08-19 Kevin Sayer Chairperson & CEO Automatic Disposition -26,756 $89.71–91.41
2026-08-13 Michael Brown Chief Legal Officer Automatic Disposition -1,700 $91.93
2026-08-11 Nicholas Augustinos Independent Director Other Disposition -1,075 --
2026-08-11 Bridgette Heller Independent Director Automatic Disposition -1,012 $88.29
2026-08-02 Mark Foletta Lead Independent Director Intent to Sell (Form 144) -2,000 $85.32
2026-08-02 Mark Foletta Lead Independent Director Automatic Disposition -4,000 $80.00–85.32
2026-07-30 Mark Foletta Lead Independent Director Intent to Sell (Form 144) -2,000 $80.00

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:22:36 · For reference only, not investment advice and not tailored to your situation.